|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/48 | |
| A61K 9/52 | |||
| A61K 47/30 | |||
| A61K 31/7056 | |||
| A61P 1/00 | |||
| A61P 3/04 |
| (11) | Number of the document | 2590634 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11804320.7 |
| Date of filing the European patent application | 2011-07-07 | |
| (97) | Date of publication of the European application | 2013-05-15 |
| (45) | Date of publication and mention of the grant of the patent | 2016-03-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/043143 |
| Date | 2011-07-07 |
| (87) | Number | WO 2012/006398 |
| Date | 2012-01-12 |
| (30) | Number | Date | Country code |
| 362946 P | 2010-07-09 | US |
| (72) |
GREEN, James, Trinca, US
WILKISON, William, Owen, US
|
| (73) |
BHV Pharma, Inc.,
3200 East Hwy. 54, Suite 104, Research Triangle Park, North Carolina 27709,
US
|
| (54) | COMBINATION IMMEDIATE/DELAYED RELEASE DELIVERY SYSTEM FOR SHORT HALF-LIFE PHARMACEUTICALS INCLUDING REMOGLIFLOZIN |
| COMBINATION IMMEDIATE/DELAYED RELEASE DELIVERY SYSTEM FOR SHORT HALF-LIFE PHARMACEUTICALS INCLUDING REMOGLIFLOZIN |